Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: Influence of prior seasonal influenza vaccination

Clinical and Vaccine Immunology

Volumn 20, Issue 4, 2013, Pages 513-516

  Song, Joon Young ^a   Cheong, Hee Jin ^a   Seo, Yu Bin ^a   Kim, In Seon ^a   Noh, Ji Yun ^a   Choi, Won Suk ^a   Lee, Jacob ^b   Jeong, Hye Won ^c   Kee, Sae Yoon ^d   Kim, Woo Joo ^a  

^a Korea University College of Medicine   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEROCONVERSION;

ADULT; ANTIBODIES, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84876494503     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00725-12     Document Type: Article

References (22)

1. Coles FB, Balzano GJ, Morse DL. 1992. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J. Am. Geriatr. Soc. 40:589-592.
2. Ikeda RM, Drabkin PD. 1992. Influenza A outbreaks in nursing homes. J. Am. Geriatr. Soc. 40:1288.
3. Sepkowitz KA. 1996. Occupationally acquired infections in health care workers. Part I. Ann. Intern. Med. 125:826-834.
4. Van Voris LP, Belshe RB, Shaffer JL. 1982. Nosocomial influenza B virus infection in the elderly. Ann. Intern. Med. 96:153-158.
5. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. 1999. Effectiveness of influenza vaccine in health care professionals: A randomized trial. JAMA 281:908-913.
6. de Juanes JR, Garcia de Codes A, Arrazola MP, Jaen F, Sanz MI, Gonzalez A. 2007. Influenza vaccination coverage among hospital personnel over three consecutive vaccination campaigns (2001-2002 to 2003-2004). Vaccine 25:201-204.
7. Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D. 2008. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 13:19017.
8. Wicker S, Rabenau HF, Doerr HW, Allwinn R. 2009. Influenza vaccination compliance among health care workers in a German university hospital. Infection 37:197-202.
9. Hannoun C, Megas F, Piercy J. 2004. Immunogenicity and protective efficacy of influenza vaccination. Virus Res. 103:133-138.
10. Kendal AP, Pereira MS, Skehel JJ. 1982. Concepts and procedures for laboratory based influenza surveillance. Viral Disease Unit, World Health Organization, Geneva, Switzerland.
11. European Committee for Proprietary Medicinal Products. 1997. Note for guidance on harmonisation of requirements for influenza vaccines CPMP/BWP/214/96. The Europen Agency for the Evaluation of Medicinal Products, London, United Kingdom.
12. Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Li P, Walravens K, Gillard P, Roman F. 2012. Characterization and long-term persistence of immune response following two doses of an AS03Aadjuvanted H1N1 influenza vaccine in healthy Japanese adults. Hum. Vaccines Immunother. 8:260-266.
13. Song JY, Cheong HJ, Seo YB, Kim IS, Noh JY, Heo JY, Choi WS, Lee J, Kim WJ. 2012. Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adults. Clin. Vaccine Immunol. 19:638-641.
14. Walker WT, de Whalley P, Andrews N, Oeser C, Casey M, Michaelis L, Hoschler K, Harrill C, Moulsdale P, Thompson B, Jones C, Chalk J, Kerridge S, John TM, Okike I, Ladhani S, Tomlinson R, Heath PT, Miller E, Faust SN, Snape MD, Finn A, Pollard AJ. 2012. H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: A multicenter follow-on study. Clin. Infect. Dis. 54:661-669.
15. Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, Park DW, Lee J, Jeong HW, Kee SY, Kim WJ. 2011. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 29:1395-1398.
16. Park SW, Lee JH, Kim ES, Kwak YG, Moon CS, Yeom JS, Lee CS. 2011. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers. Am. J. Infect. Control 39: 69-71.
17. Kobinger GP, Meunier I, Patel A, Pillet S, Gren J, Stebner S, Leung A, Neufeld JL, Kobasa D, von Messling V. 2010. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J. Infect. Dis. 201:1000-1006.
18. Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, Sabaiduc S, Chan T, Mak A, Lem M, Tang P, Patrick DM, De Serres G, Bowering D. 2010. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: First detection of the association in British Columbia, Canada. Clin. Infect. Dis. 51:1017-1027.
19. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin ME, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC. 2010. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during springsummer 2009: Four observational studies from Canada. PLoS Med. 7:e1000258. doi:10.1371/journal.pmed.1000258.
20. Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, Rappuoli R. 2011. Influenza vaccine immunology. Immunol. Rev. 239:167-177.
21. Del Giudice G, Stittelaar KJ, van Amerongen G, Simon J, Osterhaus AD, Stohr K, Rappuoli R. 2009. Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci. Transl. Med. 1:12re11.
22. Langley JM, Frenette L, Chu L, McNeil S, Halperin S, Li P, Vaughn D. 2012. A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine. BMC Infect. Dis. 12:279.